Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Ptc Therapeutics (PTCT)

18.54 -0.49 (-2.57%)

8/23/2017  2:58pm

Open:

18.84

Pre. Close:

19.03

High:

19.20

Low:

18.43

Volume:

240,024

Market Cap:

765.78M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

19.2 - 19.53

19.53 - 20.01

Low:

16.85 - 17.16

17.16 - 17.61

Close:

18.18 - 18.78

18.78 - 19.65

Technical analysis  (as of: 2017-08-23 2:38:47 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 23.31     One year: 25.52

Support:

Support1: 16.90    Support2: 14.06

Resistance:

Resistance1: 19.96    Resistance2: 21.85

Pivot:

18.63

Moving Averages:

MA(5): 18.10     MA(20): 19.00

MA(100): 15.65     MA(250): 12.86

MACD:

MACD(12,26): -0.25     Signal(12,26,9): -0.13

%K %D:

%K(14,3): 38.92     %D(3): 27.40

RSI:

RSI(14): 49.53

52-Week:

High: 21.85  Low: 4.03  Change(%): 135.9

Average Vol(K):

3-Month: 65637  10-Days 11770

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
PTCT has closed below upper band by 47.6%. Bollinger Bands are 2.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 08 Jul 2017 10:41:15 GMT
Here's Why PTC Therapeutics, Inc. Popped 45.2% in June

Mon, 08 May 2017 13:25:06 GMT
CORRECTED: PTC Therapeutics' DMD drug Emflaza to cost $35000 a year and launch ...

Tue, 22 Aug 2017 21:30:06 GMT
PTC Therapeutics Inc. (PTCT) Soars 7.39% on August 22

Wed, 28 Jun 2017 13:41:15 GMT
PTC Therapeutics Shows Strong Potential Ahead Of Ultra-Orphan-Drug Launch

Thu, 16 Mar 2017 11:15:00 GMT
PTC Therapeutics Announces Agreement to Acquire Emflaza™ for the Treatment of ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

41.04

Shares Float (M)

29.69

% Held by Insiders

20.87

% Held by Institutions

97.10

Shares Short (K)

7120

Shares Short Prior Month (K)

7250

Stock Financials

EPS

-3.810

EPS Est. Current Year

-2.290

EPS Est. Next Year

-1.710

EPS Est. Next Quarter

-0.550

Forward EPS

-2.380

Book Value (p.s.)

2.940

PEG Ratio

0.81

Profit Margin

-88.43

Operating Margin

-76.21

Return on Assets (ttm)

-17.0

Return on Equity (ttm)

-64.7

Qtrly Rev. Growth

206.8

Gross Profit (p.s.)

2.015

Sales Per Share

EBITDA (p.s.)

-2.203

Qtrly Earnings Growth

Operating Cash Flow (M)

-52.98

Levered Free Cash Flow (M)

-26.53

FoxReading.com

Valuation

P/E

-4.91

P/E Growth Ratio

-0.02

P/BV

6.36

P/S

222508176.00

P/CF

-14.49

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.